TNGX

Tango Therapeutics, Inc. (TNGX) is the lead sponsor of 5 active clinical trials listed on ClinicalTrials.gov^[3], including 5 Phase 2^[1], 5 Phase 1^[2].

TNGX has 2 Form 4 insider filings recorded at the SEC in the past 30 days^[4].